CES 2018 Features Dynafocals Smart Reading Glasses by PH Technical Labs

January 12, 2018: By Joan McKenna
    Dynafocals smart glassesDynafocals smart glasses

Ophthalmic products at CES 2018 included the Dynafocals smart reading glasses by PH Technical Labs of Plano, Texas. The conference was held Jan. 7-12 in Las Vegas.

The glasses dynamically change focus for the user based on what is viewed using a distance sensing chip and standard progressive lens. The glasses allow the user to see distant objects, computer screens, or near print without changing head positions, PH Technical says.

The company describes the glasses as providing a complete solution for all focus vision needs in a sleek, comfortable, and affordable pair of glasses.

PH Technical says it plans to launch the glasses in the middle of 2018.

The company was named a CES 2018 Innovation Awards Honoree in November.

The CES 2018 conference draws more than 180 thousand attendees and 4 thousand exhibitors.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

Carl Zeiss Meditec Announces Milestone of 1.5 Million SMILE Procedures

Heidelberg Gains US Clearance for OCT Angiography Module

ASCRS Convenes Task Force to Study CyPass Data, Make Recommendations

Bascom Palmer Treats First US Patient in Nightstar’s Trial for X-Linked Retinitis Pigmentosa

First Patient Treated in Allotex’ Trial for Allogenic Refractive Lenticules for Presbyopia

Bausch + Lomb Announces Positive Results for Loteprednol Etabonate Gel

LumiThera Set to Launch Valeda Light Delivery System for Dry AMD

Kodiak Sciences Names Jason Ehrlich, MD, PhD, Chief Medical Officer

Second Sight Receives $1.6 Million Grant from NIH to Support Orion Program

Regeneron to Invest $800 Million in New York Campus

American Women Raise Funds for Nepal Mission to Reduce Corneal Blindness

Ziemer to Add Lenticule Extraction Capabilities to LDV Z8

Stealth BioTherapeutics Raises $100 Million in Support of Elamipretide for Dry AMD

STAAR Gains US Approval of Visian Toric ICL

Sun Pharma, SPARC Announce FDA Approval for Xelpros for Open-Angle Glaucoma, Ocular Hypertension

FDA Will Review Regeneron’s Submission to Expand Eylea’s Labeling to All DR Patients

Alcon Will Locate Headquarters in Switzerland

Kodiak Sciences Files for $100 Million IPO

Iridex Announces $10 Million Public Offering

Oxford BioMedica Expands Capacity with New Facility

Coming soon

2018 Ophthalmic Deals Book: Venture Funding, Commercial Equity, and Business/Technology Sales